Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
14.61
-0.99 (-6.35%)
Oct 16, 2026, 10:20 AM EDT - Market open

Burning Rock Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1542176998237996
Market Cap Growth
68.56%213.30%-29.38%-58.57%-76.25%-58.45%
Enterprise Value
991561313103755
Last Close Price
15.6020.156.759.3022.5095.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.232.810.981.292.9012.46
PB Ratio
2.322.840.870.911.413.43
P/TBV Ratio
2.252.840.870.911.413.44

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.492.030.180.181.279.44

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.090.080.090.020.040.05
Net Debt / Equity Ratio
-0.75-0.82-0.81-0.80-0.74-0.76
Net Debt / EBITDA Ratio
6.3813.181.751.151.001.87
Net Debt / FCF Ratio
21.2712.994.852.341.632.05
Asset Turnover
0.640.630.540.410.290.21
Inventory Turnover
2.772.292.331.751.451.50
Quick Ratio
2.762.682.602.962.584.38
Current Ratio
3.052.992.923.363.064.89
Return on Equity (ROE)
-12.82%-9.92%-51.38%-67.85%-64.67%-37.35%
Return on Assets (ROA)
-5.16%-4.02%-20.93%-31.84%-31.70%-20.16%
Return on Capital Employed (ROCE)
-12.20%-9.60%-52.10%-86.20%-83.40%-41.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.09%-3.65%-68.58%-94.01%-59.50%-12.59%
FCF Yield
-1.59%-2.22%-19.33%-37.95%-32.29%-10.88%
Buyback Yield / Dilution
-0.43%-3.27%-0.53%1.46%0.29%-51.83%
SEC Filings: 10-K · 10-Q